Expertise, innovation, reliability and security are key elements of SMC’s success in its pharmaceutical and biotechnology projects. Our staff has technical know-how
as well as knowledge of the latest technology
and global regulatory requirements
, including those of the U.S. Food and Drug Administration (FDA), Canada’s Therapeutic Products Directorate (TPD) and the European Medicines Evaluation Agency (EMEA).
Because we understand the challenges facing the pharmaceutical and biotechnology industries, we design flexible facilities that facilitate operation, and we do so in fast-track mode. These strengths make SMC Consortium a key partner in the planning and design of pharmaceutical and biotechnology facilities, including research and development laboratories, pilot plants and large-scale manufacturing plants.
From the start of the project, SMC works closely with the client to define its needs, in particular by producing User Requirements Specifications (URS). This approach results in project execution that fully meets our clients’ criteria and objectives.
SMC has extensive expertise in environmental engineering and is able to help clients with environmental management and the issuance of permits.
We have developed web-based software that allows our clients to track their projects on-line.